aid: meddra
url: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/apis.yml
apis:
  - aid: meddra:meddra-api
    name: MedDRA / WHO Drug Dictionary API
    tags:
      - Adverse Events
      - Coding
      - Medical Terminology
      - Pharma
    image: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/image.png
    humanURL: https://www.meddra.org/
    baseURL: https://api.meddra.example.com
    properties:
      - url: https://www.meddra.org/
        type: Documentation
      - url: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/openapi/meddra-terminology-openapi.yml
        type: OpenAPI
      - url: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/json-schema/meddra-term-schema.json
        type: JSONSchema
      - url: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/json-ld/meddra-context.jsonld
        type: JSONLDContext
    description: >-
      MedDRA (Medical Dictionary for Regulatory Activities) and the WHO Drug Dictionary
      provide standardized medical terminology APIs for adverse event coding, drug
      safety reporting, and pharmacovigilance. APIs enable term lookup, hierarchy
      navigation, and coding validation for regulatory submissions.
common:
  - url: https://www.meddra.org/
    type: Portal
  - url: https://www.meddra.org/
    type: Website
  - url: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/openapi/meddra-terminology-openapi.yml
    type: OpenAPI
  - url: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/json-schema/meddra-term-schema.json
    type: JSONSchema
  - url: https://raw.githubusercontent.com/api-evangelist/meddra/refs/heads/main/json-ld/meddra-context.jsonld
    type: JSONLDContext
maintainer:
  name: Kin Lane
  email: kin@apievangelist.com
modified: '2026-04-28'
description: >-
  MedDRA (Medical Dictionary for Regulatory Activities) is a clinically validated
  international medical terminology dictionary used by regulatory authorities and
  the regulated biopharmaceutical industry.